WallStreetZenWallStreetZen

NASDAQ: KRYS
Krystal Biotech Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

KRYS earnings and revenue history

Current Revenue
$50.7M
Current Earnings
$10.9M
Current Profit Margin
21.6%

KRYS Return on Equity

Current Company
1.6%
Current Industry
-63.5%
Current Market
188%
KRYS's Return on Equity (1.6%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when KRYS announces earnings.

KRYS Return on Assets

Current Company
1.5%
Current Industry
2.9%
KRYS is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

KRYS Return on Capital Employed

Current Company
1.64%
Current Industry
19.5%
KRYS has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

KRYS vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
KRYS$50.70M$17.90M$10.93MN/AN/A
NUVL$0.00-$126.22M-$126.22MN/AN/A
CRSP$371.21M-$130.89M-$153.61M+160.00%N/A
BBIO$9.30M-$551.39M-$643.20M-30.80%N/A
ALPN$58.88M-$31.41M-$32.18M+142.30%N/A
View Top Biotech Stocks

KRYS earnings dates

Next earnings date
May 17, 2024

Krystal Biotech Earnings & Revenue FAQ

What were KRYS's earnings last quarter?

On Invalid Date, Krystal Biotech (NASDAQ: KRYS) reported Q4 2023 earnings per share (EPS) of $0.32, up 125.6% year over year. Total Krystal Biotech earnings for the quarter were $8.69 million. In the same quarter last year, Krystal Biotech's earnings per share (EPS) was -$1.25.

If you're new to stock investing, here's how to buy Krystal Biotech stock.

What was KRYS's earnings growth in the past year?

As of Q2 2024, Krystal Biotech's earnings has grown year over year. Krystal Biotech's earnings in the past year totalled $10.93 million.

What is KRYS's earnings date?

Krystal Biotech's earnings date is Invalid Date. Add KRYS to your watchlist to be reminded of KRYS's next earnings announcement.

What was KRYS's revenue last quarter?

On Invalid Date, Krystal Biotech (NASDAQ: KRYS) reported Q4 2023 revenue of $42.14 million up Infinity% year over year. In the same quarter last year, Krystal Biotech's revenue was $0.00.

What was KRYS's revenue growth in the past year?

As of Q2 2024, Krystal Biotech's revenue has grown null year over year. Krystal Biotech's revenue in the past year totalled $50.70 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.